Literature DB >> 15036814

Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey.

M Emre Atabek1, Duygu Fýndýk, Abdulgani Gulyuz, Ibrahim Erkul.   

Abstract

OBJECTIVE: To determine the prevalence of antibodies to hepatitis A (HAV) and E (HEV) viruses in the different areas of Konya.
METHODS: Anti-HAV and anti-HEV antibodies were investigated in 210 healthy children randomly selected (100 from rural areas and 110 from urban areas of Konya). None gave a history of previous icterus nor other signs of hepatitis, had received blood transfusion and HAV vaccine, or had been on hemodialysis.
RESULTS: Evidence of HAV infection occurred in children under the age of 6 years. The seroprevalence rate was 67.8% in rural areas and 25.8% in urban areas. This increased rapidly with age and became universal after 11 years of age in both areas. In contrast, HEV infections were not detected until children were 6-11 year olds, and the 5.2% seroprevalence rate in urban areas and 8.5% seroprevalence rate in rural areas in this age group did not significantly increase in older age group. The prevalence of anti-HAV as well as anti-HEV was significantly higher in children with poor socio-economic conditions in both areas.
CONCLUSIONS: These results suggest that HAV infection in rural areas of Konya is widespread and that environmental and socio-economic factors play a major role in its transmission. In contrast, hepatitis E is not a public health problem in Konya.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036814     DOI: 10.1016/S0168-8510(03)00123-4

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  14 in total

1.  Epidemiology of hepatitis E virus in children in the province of Van, Turkey.

Authors:  Gülsüm İclal Bayhan; Kaan Demiören; Hüseyin Güdücüoğlu
Journal:  Turk Pediatri Ars       Date:  2016-09-01

Review 2.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

3.  Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.

Authors:  Ahmet Soysal; Ibrahim Gokçe; Tamer Pehlivan; Mustafa Bakir
Journal:  Eur J Pediatr       Date:  2007-02-22       Impact factor: 3.183

4.  Shifting epidemiology of hepatitis a infection and vaccination status of children aged 6 months-12 years: time for mass vaccination.

Authors:  Burcin Nalbantoglu; Metin M Donma; Burcu Ozdilek; Erkut Karasu; Aysin Nalbantoglu
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

5.  Seroprevalence of hepatitis e virus among primary school children.

Authors:  Nural Cevahir; Melek Demir; Ali Ihsan Bozkurt; Ahmet Ergin; Ilknur Kaleli
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

6.  Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.

Authors:  Claudia Lamarca Vitral; Mônica da Silva-Nunes; Marcelo Alves Pinto; Jaqueline Mendes de Oliveira; Ana Maria Coimbra Gaspar; Rebeca Cristina Costa Pereira; Marcelo Urbano Ferreira
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

7.  HAV Immunity in Iranian Medical Students.

Authors:  Seyyed Javad Hosseini Shokouh; Alireza Dadashi; Mohamad Abiri; Iraj Zohrevand; Ahad Eshraghian; Alireza Khoshdel; Behnam Heidari; Shayan Khoshkish
Journal:  Hepat Mon       Date:  2015-03-31       Impact factor: 0.660

Review 8.  Epidemiology of Hepatitis E Virus in European Countries.

Authors:  Daniele Lapa; Maria Rosaria Capobianchi; Anna Rosa Garbuglia
Journal:  Int J Mol Sci       Date:  2015-10-27       Impact factor: 5.923

9.  Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.

Authors:  Kuan Abdoulaye Traoré; Hortense Rouamba; Yacouba Nébié; Mahamadou Sanou; Alfred S Traoré; Nicolas Barro; Pierre Roques
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

Review 10.  A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Authors:  Selim Badur; Serdar Öztürk; Alev Ozakay; Mansour Khalaf; Debasish Saha; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.